Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP541556.RAZel905b7a8m4jFt5FRlxbngZvQY9bjwH3BuWsrQGLYQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP541556.RAZel905b7a8m4jFt5FRlxbngZvQY9bjwH3BuWsrQGLYQ130_assertion type Assertion NP541556.RAZel905b7a8m4jFt5FRlxbngZvQY9bjwH3BuWsrQGLYQ130_head.
- NP541556.RAZel905b7a8m4jFt5FRlxbngZvQY9bjwH3BuWsrQGLYQ130_assertion description "[We compared the number/percentages of naive and memory CD4+ T-cells, CD38+ CD8+ T-cells, and CD28+ CD4+ and CD28+ CD8+ T-cells in patients with advanced HIV disease (baseline CD4+ count < 100) with those with less advanced (baseline CD4+ cell count > 100) HIV disease during 4 years of suppressive highly active antiretroviral therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541556.RAZel905b7a8m4jFt5FRlxbngZvQY9bjwH3BuWsrQGLYQ130_provenance.
- NP541556.RAZel905b7a8m4jFt5FRlxbngZvQY9bjwH3BuWsrQGLYQ130_assertion evidence source_evidence_literature NP541556.RAZel905b7a8m4jFt5FRlxbngZvQY9bjwH3BuWsrQGLYQ130_provenance.
- NP541556.RAZel905b7a8m4jFt5FRlxbngZvQY9bjwH3BuWsrQGLYQ130_assertion SIO_000772 16553807 NP541556.RAZel905b7a8m4jFt5FRlxbngZvQY9bjwH3BuWsrQGLYQ130_provenance.
- NP541556.RAZel905b7a8m4jFt5FRlxbngZvQY9bjwH3BuWsrQGLYQ130_assertion wasDerivedFrom befree-2016 NP541556.RAZel905b7a8m4jFt5FRlxbngZvQY9bjwH3BuWsrQGLYQ130_provenance.
- NP541556.RAZel905b7a8m4jFt5FRlxbngZvQY9bjwH3BuWsrQGLYQ130_assertion wasGeneratedBy ECO_0000203 NP541556.RAZel905b7a8m4jFt5FRlxbngZvQY9bjwH3BuWsrQGLYQ130_provenance.